metronidazole

Brand: Flagyl, Metro

⚠ BBW Prototype Drug
Drug Class: antibiotic / antiprotozoal
Drug Family: antibiotic
Subclass: nitroimidazole
Organ Systems: infectious-disease

Mechanism of Action

Prodrug reduced in anaerobic organisms to a cytotoxic nitro radical anion, which damages microbial DNA and causes strand breaks; bactericidal against obligate anaerobes and protozoa; aerobic organisms cannot reduce the drug to its active form.

microbial DNA (reactive intermediate)

Indications

  • Clostridioides difficile colitis (vancomycin or fidaxomicin preferred for severe cases)
  • bacterial vaginosis
  • trichomoniasis (drug of choice)
  • intra-abdominal infections (with cephalosporin for aerobic coverage)
  • amoebic liver abscess
  • H. pylori eradication (component)
  • anaerobic wound infections

Contraindications

  • first trimester of pregnancy (teratogenicity concerns)
  • disulfiram reaction (concurrent disulfiram or within 2 weeks)

Adverse Effects

Common

  • metallic taste
  • nausea
  • headache
  • dizziness

Serious

  • peripheral neuropathy (dose-dependent; prolonged use)
  • CNS neurotoxicity (encephalopathy, cerebellar dysfunction, seizures — mainly high-dose IV)
  • disulfiram-like reaction with alcohol
  • Clostridioides difficile superinfection (paradoxically)

Pharmacokinetics (ADME)

Absorption ~100% oral bioavailability
Distribution Protein binding <20%; Vd ~0.25–0.85 L/kg; excellent CSF penetration
Metabolism Hepatic CYP2C9 and CYP3A4 (minor) to active hydroxy-metabolite
Excretion Renal (~60–80%) and fecal
Half-life 6–12 hours
Onset 1–2 hours
Peak 1–2 hours
Duration 8–12 hours
Protein Binding <20%
Vd 0.25–0.85 L/kg

Drug Interactions

Drug / Agent Mechanism Severity
alcohol disulfiram-like reaction (flushing, nausea, tachycardia, hypotension) — avoid alcohol during and 48 hours after therapy major
warfarin CYP2C9 inhibition increases warfarin levels; INR may double major
lithium may reduce renal lithium clearance; toxicity risk moderate

Nursing Considerations

  1. Counsel patients emphatically about the disulfiram-like reaction with alcohol — avoid all alcohol (including mouthwash, food preparations) during therapy and for 48–72 hours after completion
  2. For trichomoniasis: treat both partners simultaneously regardless of symptoms; use 2 g single-dose regimen or 500 mg BID x7 days; retest at 3 months
  3. Monitor for peripheral neuropathy (tingling, numbness in extremities) with prolonged courses — generally reversible but can persist; report immediately
  4. IV metronidazole for severe C. diff or intra-abdominal anaerobic infections: infuse over 30–60 minutes; IV formulation contains significant propylene glycol (monitor for toxicity with extended infusions)

Clinical Pearls

  • Metronidazole is unique among antibiotics in its complete selectivity for obligate anaerobes — aerobic organisms cannot reduce the drug to its toxic intermediate, meaning aerobes are completely unaffected
  • The disulfiram-like reaction is not a drug allergy — it is a predictable pharmacodynamic interaction from acetaldehyde accumulation; the interaction is severe enough to warrant strict counseling and documentation

Safety Profile

Pregnancy avoid
Lactation avoid
Renal Adjustment Not required
Hepatic Adjustment Required
TDM Not required